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A B S T R A C T
Scavenger receptor class B type I (SR-BI) mediates the selective uptake of cholesteryl esters (CE) from high-
density lipoproteins (HDL). An impaired SR-BI function leads to hyperalphalipoproteinemia with elevated levels
of cholesterol transported in the HDL fraction. Accumulation of cholesterol in apolipoprotein B (apoB)-con-
taining lipoproteins has been shown to alter skin lipid composition and barrier function in mice. To investigate
whether these hypercholesterolemic effects on the skin also occur in hyperalphalipoproteinemia, we compared
skins of wild-type and SR-BI knockout (SR-BI−/−) mice. SR-BI deficiency did not affect the epidermal cholesterol
content and induced only minor changes in the ceramide subclasses. The epidermal free fatty acid (FFA) pool
was, however, enriched in short and unsaturated chains. Plasma CE levels strongly correlated with epidermal
FFA C18:1 content. The increase in epidermal FFA coincided with downregulation of cholesterol and FFA
synthesis genes, suggesting a compensatory response to increased flux of plasma cholesterol and FFAs into the
skin. Importantly, the SR-BI−/− epidermal lipid barrier showed increased permeability to ethyl-para-
minobenzoic acid, indicating an impairment of the barrier function. In conclusion, increased HDL-cholesterol
levels in SR-BI−/− mice can alter the epidermal lipid composition and lipid barrier function similarly as ob-
served in hypercholesterolemia due to elevated levels of apoB-containing lipoproteins.
1. Introduction
Lipids are important components of the epidermal stratum corneum
(SC), where they form a well-structured lipid matrix that functions as a
protective barrier preventing dehydration and the penetration of pa-
thogens and dangerous agents [1]. Cholesterol, ceramides (CERs), and
free fatty acids (FFAs) are the main lipid classes present in the SC and
are primarily synthesized by differentiating keratinocytes in the epi-
dermis [2]. At the final stage of keratinocyte differentiation, these lipids
are extruded into the intercellular space at the interface of the stratum
granulosum and the SC and processed to form the SC lipid matrix [3].
Lipids of extracutaneous origin (e.g. plasma lipids) may also con-
tribute to the formation of the matrix of SC lipids [4–7]. In plasma,
lipids are primarily transported in the core of 4 classes of lipoproteins;
chylomicrons, very-low-density lipoproteins (VLDL), low-density lipo-
proteins (LDL), and high-density lipoproteins (HDL). Expression of the
low-density lipoprotein receptor (LDLR), the apolipoprotein (apo) B/E
receptor, in the liver is essential for maintaining normal plasma lipid
levels transported by apoB-containing lipoproteins (chylomicrons,
VLDL, LDL) and, hence, mutations in the LDLR lead to hyperlipidemia
[8–10]. Recent work from our group showed that severe hypercholes-
terolemia associated with accumulation of apoB-containing lipopro-
teins can alter the composition of the epidermal lipids and the skin
barrier function in mice [11]. Currently, it remains unknown whether
the observed effects are specific for apo B-containing lipoproteins.
HDL represents a second important group of lipoprotein particles
involved in the transport of cholesterol throughout the body, especially
mediating reverse cholesterol transport. HDL particles interact with the
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ATP-binding cassette transporters ABCA1 and ABCG1 [12] to promote
cellular efflux of excess cholesterol, which are subsequently stored as
cholesteryl esters (CE) in the core of these lipoproteins after ester-
ification by the enzyme lecithin: cholesterol acyl transferase (LCAT)
[13]. CE from mature HDL particles can be delivered via the scavenger
receptor class B type I (SR-BI) to steroidogenic tissues for hormone
production or to the liver to be redistributed to the body or excreted via
the bile, the last step in the reverse cholesterol transport process
[14,15].
SR-BI is a transmembrane glycoprotein that interacts with HDL and
various native and modified lipoproteins (e.g. β-VLDL, oxidized LDL)
[16,17]. In addition to its high expression in the liver and in steroido-
genic tissues, SR-BI, like the LDLR, is also expressed in the epidermis;
especially in keratinocytes in the basal epidermal layer close to the
vascular bed in the dermis [4,7,18,19]. The expression of this receptor
decreases towards the skin surface but is increased in case of barrier
disruption or inhibition of local synthesis by statins [4,7]. In contrast
with apoB-containing lipoproteins, which deliver their lipid content via
receptor mediated uptake, smaller HDL particles can more efficiently
move through tissues (plasma to interstitial fluid) and get into the skin
[20]. In fact, the skin is one of the largest body reservoirs of HDL [21].
In both mice and humans, impaired reverse cholesterol transport
due to deficiency or polymorphisms in the gene encoding for SR-BI
results in hyperalphalipoproteinemia marked by an accumulation of
larger and abnormal HDL particles and increased HDL-cholesterol in the
circulation [10,22,23]. Among others, HDL-driven hyper-
alphalipoproteinemia, a special form of hypercholesterolemia, has been
related to altered platelet function [24,25] and reduced steroidogenesis
[23,26,27].
In this study, we aimed to investigate whether hyper-
alphalipoproteinemia and the associated increase in HDL-cholesterol
would affect the skin lipid barrier. For this purpose, we compared the
skin of SR-BI knockout (SR-BI−/−) mice, a model for hyper-
alphalipoproteinemia, to the skin of wild-type (WT) control mice of
similar age and genetic background. Hereto, we assessed the skin
morphology, the composition and organization of the epidermal lipids,
and the lipid barrier function. The experimental mice were fed a low
fat/low cholesterol diet as we aimed to specifically analyze the effects
of HDL-driven hyperalphalipoproteinemia in absence of high fat/high
cholesterol diet-induced increases in apoB-containing lipoproteins.
2. Materials and methods
2.1. Chemicals
Rodent chow diet low in fat and cholesterol (Rat and Mouse No.3
breeding diet) was purchased from Special Diets Services (United
Kingdom). We obtained ketamine and atropine from AUV Veterinary
Services (Cuijk, The Netherlands) and xylazine from ASTFarma
(Oudewater, The Netherlands). Sodium phosphate dibasic (Na2HPO4),
hematoxylin, eosin, toluidine blue, trypsin from bovine pancreas,
trypsin inhibitor, cholesterol, FFA with carbon chains ranging from 16
to 30 carbon atoms (FFA C16–30), deuterated FFA C18, deuterated FFA
C24, chloroform, acetic acid, deuterated water, natrium bromide
(NaBr), ethyl-para-aminobenzoic acid (E-PABA), trifluoroacetic acid,
synthetic CER N(24)dS(18), CER N(24)S(18), CER N(24)P(18), and CER
A(24)S(18) were obtained from Sigma-Aldrich (Zwijndrecht, The
Netherlands). Synthetic CER E(18,2)O(30)S(18) and CER[N
(C24deuterated)S(C18protonated)] were kindly provided by Evonik
Industries (Essen, Germany). Sodium chloride (NaCl) and Kaiser's gly-
cerol gelatin were purchased from Boom (Meppel, The Netherlands).
Heptane was purchased from ChemLab (Zedelgem, Belgium).
Potassium dihydrogen phosphate (KH2PO4), potassium chloride (KCl)
and Entellan® were purchased from Merck (Darmstadt, Germany).
Methanol, ethanol, isopropanol and acetonitrile were purchased from
Biosolve (Valkenswaard, The Netherlands). All solvents used were
analytical grade.
2.2. Animals
Female C57Bl/6 wild-type (WT) mice were obtained from The
Jackson laboratory and bred at the Gorlaeus laboratories. Female
homozygous SR-BI−
/− mice were kindly provided by Monty Krieger
and cross-bred at the Gorlaeus laboratories to a C57Bl/6 background.
The experimental WT group consisted of the same mice as reported
previously [11]. The mice were kept under standard laboratory con-
ditions at 20 °C and with light cycle of 12 h light/12 h dark. The mice
received water and standard low-fat chow diet ad libitum (Rat and
Mouse No. 3 breeding diet). At 16–18 weeks of age the mice were an-
esthetized with xylazine (70 mg/kg body weight), atropine (1.8 mg/kg
body weight), and ketamine (350 mg/kg body weight) followed by
retro-orbital bleeding and perfusion with phosphate buffered saline
(PBS, 8.13 g/l NaCl, 2.87 g/l Na2HPO4, 0.2 g/l KH2PO4, 0.19 g/l KCl in
milliQ water pH 7.4) at room temperature. Blood was collected in
EDTA-containing tubes. The dorsal skin of the mice was shaved and the
skin was processed further for morphological stainings, lipid and gene
expression analysis. All experiments were in agreement with National
guidelines and approved by the Animal Experiments Ethics Committee
of Leiden University.
2.3. Plasma lipid analysis
Non-fasted plasma levels of free cholesterol (FC), cholesteryl esters
(CE) and triglycerides were measured by enzymatic colorimetric assays
performed as described previously (Roche Diagnostics, Almere,
Netherlands) [28].
2.4. Skin morphology staining
4–5 μm paraffin sections of skin were stained with hematoxylin and
eosin or with toluidine blue as described previously [11]. Stained sec-
tions were mounted in Entellan® and imaged with a Zeiss Axioplan 2
light microscope (Zeiss, Best, The Netherlands). The presence of cho-
lesterol crystals was verified using a BH-2 polarized microscope
(Olympus, Leiderdorp, The Netherlands).
2.5. Liquid chromatography-mass spectrometry (LC/MS)
Skin samples without the hypodermis were stretched on a paper
filter soaked in 0.3% w/v trypsin solution in PBS (pH 7.4) overnight at
low temperature (4 °C). The next day, the skin was incubated at 37 °C
(1 h) for trypsin activation and subsequently the epidermis was iso-
lated. Afterwards, the trypsin in the samples was neutralized by
washing the samples in 0.1% w/v trypsin inhibitor in PBS (pH 7.4) and
in demi-water. After air-drying, the epidermis was stored under argon
atmosphere for further SC lipid extraction followed by LC/MS analysis,
and Fourier transform infrared spectroscopy (FTIR). Epidermal lipids
were extracted as described by Boiten et al. and the extracts were stored
in chloroform:methanol (2:1, v/v) at 4 °C under argon atmosphere for
LC/MS-based cholesterol, CER and FFA analysis [29].
2.5.1. Cholesterol and CER analysis
Epidermal cholesterol and CER analysis by LC/MS was performed as
described previously [11]. In short, epidermal lipid extracts (dried at
40 °C under a gentle flow of nitrogen) were reconstituted to a lipid
concentration of 0.3 mg/ml in heptane:chloroform:methanol
(95:2.5:2.5; v/v/v). Deuterated CER[N(C24deuterated)S(C18proto-
nated)] was added to all samples as internal standard. Reconstituted
epidermal lipid extracts (5 μl) were injected using an Acquity UPLC H-
class system (Waters, Milford, MA, USA). Separation was achieved on a
normal phase column (PVA-Sil column: 5 μm particle size,
100 × 2.1 mm i.d., YMC, Kyoto, Japan) with an eluent flow rate of
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0.8 ml/min (Supplementary Table S1). The UPLC system was connected
to a XEVO TQ-S mass spectrometer (Waters, Milford, MA, USA) with an
atmospheric pressure chemical ionization (APCI) chamber. Samples
were measured with positive ion detection mode for full scans
(350–1200 amu) and the area under the curve (AUC) was determined
using Waters MassLynx 4.1 software and corrected for the internal
standard. Cholesterol data was plotted as absolute amount of choles-
terol per epidermis weight (μg/mg) based on a calibration curve of
cholesterol. CER composition data was plotted as relative percentage of
each ceramide subclass based on AUC values corrected for internal
standard. This method can underestimate the level of [EO] subclass.
CERs were named as described by Motta et al. (1993) depicting the acyl
chains (non-hydroxy fatty acid [N]; α-hydroxy fatty acid [A] or ester-
ified ω-hydroxy fatty acid [EO]) and the sphingoid base (dihydro-
sphingosine, [dS]; sphingosine [S] or phytosphingosine [P]) [30].
2.5.2. FFA analysis
Epidermal FFA analysis by LC/MS was performed using the same
UPLC/MS system described above. Epidermal lipid extracts (dried at
40 °C under a gentle flow of nitrogen) were reconstituted in isopropanol
to a lipid concentration of 0.75 mg/ml. Next, internal standards deut-
erated FFA C18 and deuterated FFA C24 were added to the samples.
Reconstituted lipid extracts (2 μl) were injected in the UPLC system into
a Purospher Star LiChroCART reverse phase column (3 μm particle size,
55 × 2 mm i.d., Merck, Darmstadt, Germany) with an eluent flow rate
of 0.5 ml/min (Supplementary Table S2). The XEVO TQ-S mass spec-
trometer coupled to the APCI (probe temperature: 425 °C, discharge
current 3 μA.) was set to negative ion mode and the detector measured
full scans (200–550 amu). Data was analyzed using Waters MassLynx
4.1 software to determine the AUC. The AUC was corrected for the
internal standard FFA C24 and calculated to absolute amounts based on
calibration curves of FFA C16-C30. FFA composition was plotted in
absolute amounts and as relative percentage to the total amount FFA
detected (% w/w). FFA C16:0 and C18:0 were not plotted as they were
present in the solvent used for lipid extraction due to manufacturer's
contamination with these FAs. Unsaturated FFA C16-C18, important
components of sebum lipids, were plotted separately [31,32].
2.6. CER fragmentation by (LC/)MS/MS
Murine CERs present in the epidermal lipid extract (in chloroform-
methanol 2:1) were separated using the UPLC-H class system described
above for CER analysis while maintaining a continuous solvent flow of
98% heptane and 2% heptane:isopropanol:ethanol (50:25:25; v/v/v) at
0.8 ml/min. Fragmentation spectra (MS/MS) of murine epidermal CERs
were obtained using the XEVO TQ-S mass spectrometer. The collision
energy for MS/MS was set to 30 eV. All other parameters of the XEVO
TQ-S mass spectrometer were identical to the setup described for CER
analysis. Parent ions with masses of 647, 653 and 663 amu were
fragmented and identification of the fragments was performed using
Waters MassLynx 4.1.
2.7. q-PCR
Total RNA was isolated from skin samples after removal of the hy-
podermis using the guanidinium thiocyanate method [33]. 1 μg of RNA
was used to synthesize cDNA using M-MuLV reverse transcriptase.
SYBR Green Technology was used for the quantitative gene expression
analysis with a 7500 Fast real-time PCR system (Applied Biosystems,
Foster City, CA, USA). Gene expression was normalized by the expres-
sion of the housekeeping genes ribosomal protein, large, P0 (RPL0),
cytochrome c-1 (CYC1) and ribosomal protein S20 (RPS20). Relative
gene expression was determined as the difference between the average
threshold cycle (Ct) of the housekeeping genes and the Ct of the target
gene followed by raising this difference to the power of 2. The ex-
pression of target genes in the SR-BI−/− skin were plotted as relative
fold change compared to the WT controls. Forward and reverse primer
sequences of the housekeeping genes and genes of interest are available
in Supplementary Table S3.
2.8. Fourier transformed infrared spectroscopy
Epidermis was hydrated for 24 h over 27% sodium bromide in
deuterated water and placed between two silver bromide windows for
Fourier transform infrared spectroscopy (FTIR) measurements (Varian
670-IR spectrometer, Agilent Technologies, Inc., Santa Clara, CA). The
spectrometer was equipped with a broad-band mercury cadmium tell-
uride detector. FTIR spectra (600–4000 cm−1) were collected within a
temperature range from 0 to 90 °C rising at a rate of 0.5 °C/min.
Deconvolution of the spectra (half width of 4 cm−1; enhancement
factor of 1.7) was processed with Resolutions Pro 4.1 (Varian Inc.)
software. Lateral organization of the SC lipids was monitored by CH2
rocking vibrations (710–750 cm−1). The ratio between the peak area at
730 cm−1 and the area peak at 719 cm−1 was used to assess changes in
the fraction of lipids adopting the orthorhombic phase at 32 °C (skin
temperature). This area ratio was calculated by curve fitting these two
main peaks in the region of CH2 rocking vibrations of the FTIR spectra
using a Lorentzian peak function. The transition temperature between
the orthorhombic and hexagonal phases was determined by the dis-
appearance of the vibration at the 730 cm−1.
2.9. Transepidermal water loss (TEWL)
Transepidermal water loss (TEWL) was measured in the skin of WT
and SR-BI−/− mice to assess skin barrier function. For TEWL mea-
surements the mice were anesthetized as described on Section 2.2 and
their dorsal skin was shaved. The closed-chamber of the evaporimeter
(Aqua Flux AF200, Biox Systems Ltd., London, UK) was placed in up-
right position on their dorsal skin perpendicular to the skin surface.
Transepidermal water loss was measured for 120 s. The temperature in
the room (22 °C) and the humidity (50.1%) were controlled during the
measurements.
2.10. Murine lipid model membranes (mLMM)
Murine lipid model membranes (mLMM) mimicking either the lipid
composition of the epidermis of WT or SR-BI−
/− mice were prepared
based on the lipid composition determined by LC/MS in this study. All
mLMM were prepared with a CER mixture containing CER N(24)dS(18),
CER N(24)S(18), CER N(24)P(18), CER A(24)S(18), CER E(18,2)O(30)S
(18) in a molar ratio of 40.5:36:5:14.5:4, respectively. The FFAs were
composed of FFA C16:0, C18:0, C20:0, C20:1, C22:0, C22:1, C24:0,
C26:0 in a molar ratio representative of either WT or SR-BI−
/− mice SC
FFA composition (Table 1). Briefly, for mLMM preparation all lipids
were collected in a glass vial, dried under a gentle nitrogen flow and
reconstituted in hexane:ethanol (2:1, v/v) to a lipid concentration of
5 mg/ml. The lipid mixtures were sprayed under a gentle nitrogen flow
onto a polycarbonate membrane (0.05 μm pore size, 25 mm i.d.,
Whatmann, Kent, UK) using a 100 μl Hamilton syringe, Bonaduz,
Table 1
FFA composition of mLMM prepared for permeability studies.
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Switzerland). Spraying (5 μl/min) was performed by a Camag Linomat
IV with an extended y-axis arm (Muttenz, Switzerland) to form a
homogeneous square of 10 × 10 mm. Sprayed mLMMs were equili-
brated at 85 °C for 10 min, cooled down to room temperature for sto-
rage under argon atmosphere until their use in the permeability studies.
2.11. Lamellar and lateral organization of mLMM
X-ray diffraction studies (station BM26B, European Synchrotron
Radiation facility, Grenoble, France) were used to determine both la-
mellar and lateral organization of the mLMM. After hydration (24 h,
27% sodium bromide in demiwater) the mLMM were mounted into a
sample holder (parallel to X-ray beam; X-ray wavelength of 0.1034 nm,
sample-to-detector distance of 1980 mm) with the temperature con-
trolled at 25 °C. Small angle X-ray diffraction data were collected on a
Pilatus 1 M detector (1043 × 981 pixels at 172 × 172 μm spatial re-
solution) calibrated using silver behenate (d = 5.838 nm). Wide angle
X-ray diffraction data were collected on a Pilatus 300 K (1475 × 195
pixels at 172 × 172 μm spatial resolution, sample-to-detector distance
of 3110 mm) calibrated using the high density polyethylene (HDPE,
d = 0.416 nm and 0.378 nm). The scattering intensity I (in arbitrary
units) of the static diffraction patterns (collected for 60 s at two posi-
tions) was calculated as a function of the scattering vector q (in re-
ciprocal nm). Vector q was determined as shown in Eq. (1) with θ re-
presenting the scattering angle and λ the wavelength. Diffraction rings
were integrated over an angle of 40o. The periodicity (d-spacing) of the
lamellar phase was calculated as shown in Eq. (2) using the positions of
a sequence of equidistant peaks (qn) with n representing the order
number of the diffraction peak.
=q (4πsinθ)/λ (1)
=d q2nπ/ n (2)
2.12. Permeability studies with mLMM
Ethyl-para-aminobenzoic (E-PABA) was used as a model drug to
assess the functionality of the mLMMs as a lipid barrier. mLMMs were
mounted into Permegear inline diffusion cells (0.282 cm2 diffusion
area, Bethlehem PA, USA). The donor phase was composed of saturated
E-PABA solution (0.65 mg/ml, pH 5.0), while the acceptor phase was
comprised of PBS (pH 7.4, stirring at 50 rpm, flow rate 2–2.5 ml/min).
For 10 h the acceptor PBS phase was collected in 1 h fractions (Isco
Retriever IV; Teledyne Isco, Lincoln NE, USA) and the E-PABA content
was determined by UPLC-UV (Waters, Etten-Leur, The Netherlands)
with acetonitrile with 0.1% trifluoroacetic acid:milliQ (40:60; v/v) as
mobile phase (flow rate of 0.5 ml/min). Separation occurred in a re-
versed phase C18 column (Alltima, C-18, 1.7 μm i.d., 2.1 × 50 mm,
Waters, Ireland) followed by UV detection (excitation wave-
length = 286 nm). A calibration curve of E-PABA in methanol was
included in the UPLC-UV analysis for E-PABA quantification. Data was
analyzed with the software TargetLynx. Average steady-state fluxes
were calculated as the average flux measured from 3.5 to 10.5 h.
2.13. Statistical analysis
Statistical analysis was performed using GraphPad Prism 7
(GraphPad Software Inc., CA, USA). Data are presented as
means ± SD. Significant differences between groups were determined
by two-tailed unpaired students t-Test. Correlations between para-
meters were determined using a Pearson's correlation coefficient ana-
lysis and linear regression. P values below 0.05 were considered sig-
nificant.
3. Results
3.1. Plasma lipid profile and skin morphology
The plasma lipid profile of non-fasted female WT and SR-BI−
/−
mice was determined by enzymatic colorimetric assays (Fig. 1a). On a
low-fat chow diet SR-BI deficiency in mice generally results in increased
plasma cholesterol levels driven by an increase in HDL-cholesterol [10].
In agreement, SR-BI−/− mice in this study displayed a hypercholes-
terolemic plasma lipid profile marked by a significant increase in FC
(1.20 ± 0.25 μg/μl plasma; p < 0.0001) and CE (1.37 ± 0.3 μg/μl
plasma; p < 0.0001) levels compared to normolipidemic WT controls
(FC 0.36 ± 0.05 μg/μl plasma; CE0.85 ± 0.08 μg/μl plasma). The
levels of plasma triglycerides in SR-BI−
/− mice did not differ from those
of WT mice.
Next, we evaluated the morphology of the skin of the mice by he-
matoxylin and eosin or toluidine blue stainings of paraffin sections
(Fig. 1b). Similarly to WT controls, the skin of SR-BI−
/− mice showed a
thin SC, no epidermal hyperproliferation, and no evidence of in-
flammation as illustrated by the absence of immune cell infiltrates. The
morphology of the dermis was also not altered. Polarized microscopy
did not reveal the presence of cholesterol crystals in the sections (data
not shown).
3.2. Epidermal lipid composition
The three main barrier lipid classes (cholesterol, CERs and FFAs) in
the epidermis of SR-BI−
/− mice were analyzed by LC/MS and compared
to WT controls. The amount of cholesterol in the SR-BI−
/− epidermis
(27.4 ± 5.3 μg/mg epidermis) was comparable to the WT control
(28.7 ± 3.1 μg/mg epidermis) (Fig. 2a). In both WT and SR-BI−/−
Fig. 1. Non-fasted plasma lipids levels and skin morphology of WT and SR-
BI−
/− mice. a. Plasma levels of free cholesterol (FC), cholesteryl esters (CE),
and triglycerides (TG) (n = 5–6 animals/group). b. Representative paraffin
sections of skin stained with hematoxylin and eosin (HE) or toluidine blue (TB).
The interface between epidermis and dermis is marked by a black dashed line.
Scale bar: 50 μm. Data shown as mean ± SD. Significant differences between
groups were determined by two-tailed unpaired student's t-Test. **p < 0.01
and ****p < 0.0001.
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epidermis seven subclasses of CER were detected: CER NdS, CER NS,
CER NP, CER AdS, CER AS, CER EOdS, and CER EOS (Fig. 2b-c). In the
epidermis of SR-BI−
/− mice, the abundance of CER AS (10.8 ± 0.6%)
was lower than in the WT control (13.5 ± 1.1%; p < 0.01). In con-
trast, the abundance of CER EOS was increased in the SR-BI−/− epi-
dermis (6.9 ± 1.0%) compared to the WT epidermis (4.6 ± 0.7%;
p < 0.01). CER NP and CER AdS were not fully separated in the ion
map; thus, these CER subclasses were grouped together, accounting for
nearly 5% of the total CER content in the epidermis of both types of
mice. Interestingly, a slight increase in the average CER chain length
was observed in the SR-BI−/− epidermis for the non-ω-esterified (CER
[nonEO]) (42.3 ± 0.1 carbon atoms) and for the ω-esterified (CER
[EO]) (68.2 ± 0.1 carbon atoms) CER subclasses compared to the WT
epidermis (42.0 ± 0.1 and 67.5 ± 0.1 carbon atoms, respectively,
p < 0.005) (Fig. 2d-e and Supplementary Fig. S1).
The CER chain length distribution revealed unusual abundance of
CERs containing odd-numbered carbon chains (Fig. 2d-e). In particular,
CER[nonEO] containing 43 carbons atoms and CER[EO] containing 67
carbon atoms were abundantly present in both WT and SR-BI−/− epi-
dermis. Further investigation with MS/MS fragmentation of CER NS
C42 and CER NS C43, two CERs abundantly present in the epidermis,
showed clear fragments for the fatty acid chain and the sphingosine
base of these CERs as previously described [34]. For CER NS C42 with
the parent ion [M + H-H2O]+ (m/z 632.3), fragments related to a fatty
acid chain of 24 carbons atoms were detected at m/z 368.3 [M + H-
C16H31OH]+. Moreover, highly abundant fragments characteristic of a
sphingosine base with 18 carbon atoms were found at m/z 252.3
[M + H-FA chain-CH3OH]+, 264.3 [M + H-FA chain- H2O]+ and
282.2 [M + H-FA chain]+. Additionally, [M + H-FA chain- H2O]+
fragments, characteristic of sphingosine bases containing 16 and 17
carbon atoms, were detected at lower abundance at m/z 236.1 and
250.1, respectively. In contrast, fragmentation of the CER NS C43
parent ion [(M + H)-H2O]+ at m/z 646.6 showed high abundance of
fragments typical of a sphingoid base of 17 carbon atoms at m/z 238.1
[M + H-FA chain- CH3OH]+, 250.1 [M + H-FA chain- H2O]+, 268.1
[M + H-FA chain]+. In addition, an abundant fragment of fatty acid
with a chain of 26 carbons [M + H– C18H35OH]+ was detected at m/z
396.2.
Epidermal FFA species with carbon chains ranging from 20 to 30
carbon atoms and abundant monounsaturated species were quantified
by LC/MS (Fig. 3a-b). Significant differences in the FFA profile between
the SR-BI−/− and WT controls were detected. The epidermis of SR-
BI−
/− mice contained higher levels of FFAs with a chain length from 20
to 30 carbon atoms per mg of epidermis compared to WT controls
(3.4 ± 0.5 vs. 6.2 ± 0.1 μg FFA/mg epidermis; p < 0.01) (Fig. 3c
and Supplementary Fig. S2). In the epidermis of both types of mice FFA
C24:0 and FFA C26:0 were the most abundant FFA species. When fo-
cusing on the relative values (μg FFA/μg total FFA × 100%), FFA C26:0
represented 44% of the FFA species in the WT epidermis, while FFA
C24:0 comprised 25% (Fig. 3b). In contrast, in the epidermis of SR-
BI−/− mice FFA C24 and FFA C26:0 were nearly equally abundant as a
result of a strong reduction in the abundance of FFA C26:0 to only 28%
(p < 0.0001). Furthermore, the abundance of monounsaturated FFAs
showed a 2-fold (p < 0.05) increase in the SR-BI−
/− epidermis
(Fig. 3d); in particular, the abundance of monounsaturated FFA C20:1
(16%) was markedly increased compared to the WT controls (7.4%;
p < 0.0001). FFAs with a chain length containing< 24 carbon atoms
accounted for approximately 30% of the FFA species present in the
epidermis of SR-BI−/− mice, while in WT mice these FFAs comprised
17% of FFAs (Fig. 3e). As a result, the mean carbon chain length of the
FFAs (including both saturated and unsaturated FFAs) in the SR-BI−/−
mice was shorter than in the WT counterparts (Fig. 3f; p < 0.01).
3.3. Plasma cholesterol esters and skin FFA C18:1 and FFA C20:1 content
Our previous studies showed that the epidermis of hypercholester-
olemic apolipoprotein E knockout mice (APOE−/−) with severely ele-
vated plasma CE levels is significantly enriched in FFA C18:1 [11].
Likewise, in the current study SR-BI−/− mice with a mild increase in
plasma CE exhibited higher levels of epidermal FFA C18:1 (Fig. 4a).
Therefore, the plasma CE concentration was plotted against the levels of
FFA C18:1 in the epidermis of SR-BI−/− mice (current study) and in the
epidermis of APOE−/− mice (previously published study) [11]. The
plasma CE levels of WT, SR-BI−/− (moderately elevated CE) and
APOE−/− (severely elevated CE) mice showed a strong positive corre-
lation with epidermal FFA C18:1 levels (Pearson's r = 0.9510,
p < 0.0001). In the epidermis FFA C18:1 can be elongated to FA C20:1
[35]. Correspondingly, the epidermal levels of FFA C18:1 showed a
significant linear correlation with the epidermal levels of FFA C20:1
(Pearson's r = 0.9448, p = 0.0001; Fig. 4c).
3.4. Skin gene expression
To gain insight in the effects and underlying causes of differences
observed between the barrier lipid profile of WT control and SR-BI−
/−
mice, the expression of genes involved in skin lipid biosynthesis, up-
take, efflux and degration was analyzed by qPCR. In the skin of SR-
BI−
/− mice the expressions of HMGCS1 (cholesterol synthesis) and
LDLR (lipoprotein uptake) were strongly downregulated (1.7-fold and
2.4-fold reduction, respectively) as compared to WT controls
(p < 0.05) (Fig. 5a). For the CER metabolic pathways, comparable
mRNA levels of CERS3 (sphingolipid-based ceramice synthesis) were
observed in the skin of WT and SR-BI−
/− mice, while GBA (gluco-
sylceramide metabolism) expression was reduced in the SR-BI−
/− skin
(1.6-fold, p < 0.05; Fig. 5a). Regarding FFAs in the skin (Fig. 5b),
significantly lower mRNA levels of ACACA (2.1-fold; p < 0.01) and
FAS (1.7-fold; p < 0.05), key enzymes in fatty acid synthesis, were
detected in the SR-BI−
/− skin, which was associated with a parallel
reduction in the expression of ELOVL1 (fatty acid chain elongation)
(2.6-fold, p < 0.05). SCD1 expression (production of monounsaturated
FFAs) in SR-BI−
/− skin was equivalent to that observed in the WT
controls. No significant differences were observed in the expression of
genes encoding for ATP-binding cassette transporters, ceramide de-
gradation enzymes and other elongases (Supplementary Fig. S3). De-
spite the recently described effect of SR-BI knockdown on peroxisome
proliferator-activated receptors [36], no differences on mRNA levels
were noted for these genes in our experimental setting. In addition, in
agreement with the morphological stainings, no significant differences
were observed in the expression of genes related to keratinocyte pro-
liferation and differentiation (IVL, FLG, K10) (data not shown).
3.5. Lateral lipid organization
The epidermal lipid composition influences the lateral packing of
these lipids, one of the determining parameters for the functionality of
the skin barrier. The lateral lipid organization of the SR-BI−
/− epi-
dermis was analyzed by FTIR and compared to WT controls. In the
spectrum region of the CH2 rocking vibrations (710–740 cm−1) a
Fig. 2. CER composition in the epidermis of WT and SR-BI−/− mice determined by LC/MS analysis. (a) Schematic representation of the molecular structure of CERs
subclasses named as described by Motta et al. (1993); (b) CER profile depicting the detected CER subclasses (NdS, NS, NP, AdS, AS, EOdS, EOS); (c) average total
chain length of CERs with non-ω-esterified (CER[nonEO]) and ω-esterified (CER[EO]) fatty acid chains in their acyl chain; (d-e) CER chain length distribution of CER
[nonEO] and CER[EO]; (f) MS/MS fragmentation of CER NS C42 and CER NS C43 showing an ion spectra in the range 200–700 m/z. Values are plotted as
mean ± SD (n = 3 animals/group). Statistical significance was determined by two-tailed unpaired student's t-Test. **p < 0.01.
R. Martins Cardoso, et al. BBA - Molecular and Cell Biology of Lipids 1865 (2020) 158592
6
doublet at 710 cm−1 and at 730 cm−1, indicative of a dense orthor-
hombic lateral lipid packing, was present in both WT and SR-BI−
/−
epidermis (Fig. 6a). At 32 °C (skin surface temperature) the fraction of
lipids adopting an orthorhombic organization was comparable between
the groups: a similar ratio between the peak area at 730 cm−1 and at
719 cm−1 was observed (Fig. 6b). The orthorhombic to hexagonal
transition temperature was determined by the disappearance of the
peak at 730 cm−1 as a function of temperature. This transition tem-
perature varied between 38 °C and 44 °C in both groups (Fig. 6c).
3.6. Lipid barrier function in vivo and in permeability studies using mLMMs
In non-nude mice, the isolation of SC or viable epidermis is ham-
pered by the large number of hair follicles present in their skin. In
addition, hair follicles may offer another route of permeation to com-
pounds, which in turn compromises the analysis of the effects of the
altered lipid barrier function [37,38]. Nonetheless, the inside-outside
skin barrier function was analyzed in vivo by transepidermal water loss
measurements; however, no differences were noted between SR-BI−
/−
(12.5 ± 0.9 g/(m2 h)) and WT (12.5 ± 0.7 g/(m2 h)) mice. Next,
mLMMs were used as substitutes to investigate the specific impact of the
altered epidermal FFA composition on the outside-inside lipid barrier
function of SR-BI−
/− mice. Small-angle X-ray diffraction showed that
the lipids in the WTLMM and the SR-BI−
/−
LMM were organized in both
short and long periodicity phases (Fig. 7a). The repeated distance of the
long periodicity phase was increased in the SR-BI−
/−
LMM compared to
the WTLMM (p < 0.0001), but the short periodicity phase did not differ
between both mLMM (Supplementary Fig. S4). Additionally, in both
WTLMM and the SR-BI−
/−
LMM a high fraction of lipids in these synthetic
models adopted an orthorhombic lateral packing characterized by the
presence of two peaks at a position corresponding to a spacing of
0.416 nm and 0.378 nm in the wide-angle X-ray diffraction studies
(Fig. 7b). Next, the lipid barrier function of WTLMM and the SR-BI−
/−
LMM
was assessed by measuring their permeability to E-PABA. The flux of E-
PABA through both types of synthetic lipid membranes reached a
steady-state after 3 h (Fig. 7c). In the steady-state, the SR-BI−
/−
LMM
showed nearly 2-fold higher permeability to E-PABA compared to the
control WTLMM (27.3 ± 2.4 vs. 13.9 ± 2.2 μg/cm2/h, respectively;
p < 0.0001) (Fig. 7d). At the end of the experiment, nearly 100% of E-
PABA was recovered in all groups measuring the donor and acceptor
phases (data not shown).
Fig. 3. FFA composition in the epidermis of WT and SR-BI−/− mice determined by LC/MS analysis. (a) Schematic representation of the molecular structure of
saturated and monounsaturated FFAs; (b) FFA profile; (c) Total FFA content (C20-C30) per mg of extracted epidermis; (d) FFA unsaturation ratio (MUFA- mono-
unsaturated fatty acid, SFA- saturated fatty acid); (e) Abundance of FFA chains with< 24 carbons atoms; (f) average FFA chain length. Values are plotted as
mean ± SD (n = 3 animals/group). Statistical significance was determined by two-tailed unpaired student's t-Test. *p < 0.05; **p < 0.01; ****p < 0.0001.
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4. Discussion
Despite the protective role of HDL in reverse cholesterol transport,
we showed in this study that HDL-associated hyper-
alphalipoproteinemia can alter the epidermal lipid composition;
thereby, negatively impacting the lipid barrier function of the skin.
Additionally, these results support the hypothesis that the plasma levels
of CE, independent of the type of lipoprotein carrier, play a crucial role
in the maintenance of a proper skin barrier function.
Disruption of SR-BI in mice impairs the clearance of HDL-CE from
the circulation [39,40], which in turn leads to inhibition of LCAT ac-
tivity and consequent FC accumulation [41]. Hence, SR-BI−/− mice,
even on a low-fat/low cholesterol diet, develop a mild hyper-
alphalipoproteinemia characterized by increases in both FC and CE
transported in the HDL fraction [10]. In vitro, SR-BI knockdown in
human skin equivalents did not affect the cholesterol content of these
skin models but led to downregulation of relevant lipid metabolism
genes (LDLR, PPAR-α, PPAR-γ) [36]. Similarly, hyper-
alphalipoproteinemia in SR-BI−/− mice did not translate into changes
in the epidermal cholesterol fraction in the skin of these mice. However,
an increased flux of plasma cholesterol into their skin is expected as
evidenced by downregulation of LDLR and HMGCS1; thereby, main-
taining normal FC levels in the SR-BI−/− skin [11,42]. In addition, it is
important to note that cholesterol in the skin can be found as FC, CE,
cholesterol sulphate and oxysterols [43,44]. In the SC, cholesterol sul-
phate comprises a minor fraction of the sterol content while FC is the
major sterol component of the lipid matrix [45]. However, modified
cholesterol species could not be measured with our LC/MS method and
we cannot exclude that changes in the levels of these species contribute
to the preserved FC content in the SC.
As previously described in APOE−/− mice [11], unsaturated and
short chain FFA species (below 24 carbon atoms) were strongly
Fig. 4. Correlation between CE concentration and unsaturated FFAs in WT, SR-
BI−/− and APOE−/− murine epidermis. a. Epidermal levels of FFA C18:1; b.
correlation between plasma CE concentration and epidermal FFA C18:1; c.
correlation between epidermal FFA C18:1 and FFA C20:1. Plasma CE levels
were determined by colorimetric enzymatic assays performed according to
manufacturer's instructions. Epidermal FFA C18:1 and FFA C20:1 were de-
termined by LC/MS analysis. Data regarding plasma CE, epidermal FFA C18:1
and FFA C20:1 levels of APOE−/− mice were obtained from a previous pub-
lication [11]. Data shown as mean ± SD. Significant differences among groups
were determined using One-way ANOVA with Holm-Šídák post-hoc test
(*p < 0.05; **p < 0.01; ***p < 0.001). Correlation between parameters
were analyzed using Pearson's correlation analysis (r and p values) and linear
regression (grey line).
Fig. 5. Effect of SR-BI deficiency on the expression of genes involved in lipid
uptake and synthesis in the skin. Relative mRNA expression levels of genes
involved in (a) cholesterol and CER synthesis and (b) FFA synthesis. Genes and
their respective encoded proteins/receptors: HMGCS1–3-hydroxy-3-methyl-
glutaryl-Coenzyme A synthase 1; LDLR - low density lipoprotein receptor;
CERS3 - ceramide synthase 3; GBA – glucocerebrosidase; ACACA - acetyl-
Coenzyme A carboxylase alpha; FAS – fatty acid synthase; ELOVL1 - elongase of
very long chain fatty acids 1; SCD1 - stearoyl-Coenzyme A desaturase 1. Values
are plotted as mean ± SD representing the fold change expression compared to
the WT control (n = 5–6 animals/group). Statistical significance was de-
termined by two-tailed unpaired student's t-Test. *p < 0.05; **p < 0.01.
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augmented in the epidermis of SR-BI−/− mice, which also showed
downregulation of genes involved in FFA synthesis (ACACA, FAS) and
elongation (ELOVL1) compared to WT controls. Although CERs and
FFAs share biosynthetic pathways [46,47], the shift towards short chain
and unsaturated FFA species in the SR-BI−/− epidermis did not result in
a comparable profile in the CER composition, where only minor dif-
ferences were observed in the percentage of a few subclasses compared
to the WT controls. Thus, the altered FFA profile in the epidermal
barrier of SR-BI−/− mice is likely not related to the biosynthetic
pathway shared with CER but has rather an extracutaneous origin.
Analysis of the epidermal lipids also revealed increased amounts of
FFA C18:1 in SR-BI−/− mice. As previously indicated, the LCAT activity
is inhibited in the SR-BI−/− mice due to higher plasma levels of CE.
Subbaiah et al. demonstrated that low activity of LCAT in mice in-
creases circulating levels of C16:0- and C18:1-containing CE, suggesting
a direct link between C18:1-containing CE in plasma and elevated
epidermal FFA C18:1 [48]. The changes in the epidermal FFA species of
the mild hypercholesterolemic SR-BI−/− mice showed a similar trend
as that recently reported for the severely hypercholesterolemic
APOE−/− mice [11]. In addition to their increased circulating CE
concentrations, the epidermis of both SR-BI−/− and APOE−/− mice are
enriched in FFA C18:1 and FFA C20:1, though to a lesser extend in the
epidermis of SR-BI−/− mice. Simultaneous exposure of HaCaT kerati-
nocytes to FFA C18:1 and 25-hydroxy cholesterol resulted in down-
regulation of HMGCoA synthase and a lower rate of acetate in-
corporation into FFA synthesis [42]. Hence, a higher flux of plasma CE
into the epidermis of SR-BI−/− mice (similarly to APOE−/− mice) can
be expected, which is also supported by the strong correlations between
plasma CE and epidermal FFA C18:1 and the robust correlation be-
tween epidermal C18:1 and its elongated product FFA C20:1 in the
epidermis.
Alterations in the epidermal lipid composition can affect the lipid
organization and the functionality of the skin barrier [47]. In particular,
short and unsaturated FFAs have been described to reduce the density
of the lipid packing even in the presence of a similar CER composition
[49,50]. Here, we analyzed the contribution of the altered lipid profile
to the outside-inside lipid barrier function using LMMs. Our results
show that a minor increase in the short chain FFA fraction in LMMs can
preserve the dense orthorhombic packing while increasing the mobility
of the lipids within the lipid matrix, which in turn translates into a more
permeable outside-inside lipid barrier [51]. In vivo transepidermal
water loss measurements in SR-BI−/− mice revealed a functional in-
side-outside skin barrier despite the alteration in epidermal lipids (en-
riched in short chain FFAs). It is important to note that in the in vivo
situation trans-corneocytes water transport, as well as hair follicles and
other surface lipids will contribute to/influence the maintenance of
transepidermal water loss levels. Hence, although the barrier lipids in
the SR-BI−/− epidermis showed a dense orthorhombic organization,
the lipid composition of the SR-BI−/−LMM (enriched in short chain FFAs)
resulted in a more permeable outside-inside lipid barrier.
Although SR-BI is expressed in both murine and human keratino-
cytes, its specific contribution to the skin lipid homeostasis is not yet
clear due the lack of an in vivo keratinocyte-specific knockout mouse
model. Recent data from a study using human skin equivalents with
Fig. 6. Lateral lipid organization in WT and SR-BI−/− epidermis. Lateral lipid
organization was assessed by FTIR. (a) CH2 rocking vibrations (710–740 cm−1)
were plotted as a function of temperature (0-60 °C) to determine the lateral
lipid packing; (b) area ratio between the peak at 730 cm−1 and the peak at
719 cm−1 at 32 °C (skin surface temperature); (c) average transition tem-
perature from orthorhombic and hexagonal phases. Values are plotted as
mean ± SD (n = 3–4 animals/group). No statistical significant differences
were observed by two-tailed unpaired student's t-Test.
Fig. 7. Lamellar and lateral lipid organizations in the WTLMM and SR-BI−
/−
LMM
and their permeability to E-PABA. a–b. Lamellar and lateral organizations of the
mLMM were determined by small- and wide-angle X-ray diffraction studies,
respectively. Long periodicity phase order indicated in Arabic numbers (1–3),
short periodicity phase orders indicated in Roman numbers (I-II), and the re-
flection of crystalline cholesterol indicated with an asterisk (*). c. Permeability
of WTLMM and SR-BI−
/−
LMM to E-PABA over time. d. Average steady-state flux of
E-PABA measured from 3.5 to 10.5 h. Values are plotted as mean ± SD; re-
presentative of three different experiments (total n = 6–7 mLMMs/group).
Statistical significance was determined by two-tailed unpaired student's t-Test.
****p < 0.0001.
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siRNA-induced knockdown of SR-BI suggests an involvement of SR-BI in
lipid regulation in the upper epidermal layer; in particular in CER
metabolism [36]. In our study, the CER composition was preserved in
the total body SR-BI−/− mice while both cholesterol and FFA meta-
bolism were shifted to a compensatory gene expression profile. This
indicates that the hyperalphalipoproteinemia rather than the local ab-
sence of SR-BI in the skin may be the driving factor to the observed
changes in epidermal lipids in these mice.
In conclusion, this study shows that hypercholesterolemia-related to
elevated circulating levels of HDL particles alters the epidermal lipid
composition, resulting in a compromised lipid barrier function in young
adult SR-BI−/− mice on a low fat chow diet. In addition, a clear cor-
relation between plasma CE levels and epidermal levels of FA C18:1 and
FA C20:1 in hypercholesterolemic mice indicates that increased circu-
lating CE may have a decisive role in the development of this skin
phenotype. Although to date skin related problems have not been de-
scribed in patients with SR-BI polymorphisms or hyper-
alphalipoproteinemia, this study demonstrates the relevance of ana-
lyzing the SC lipid composition in these patients to prevent the
development of upcoming abnormalities in the functionality of the skin
barrier.
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